The National Academies Testimony before Congress

Public Laws Containing Studies for the National Academies

Briefings to Congress

Congressionally Mandated Reports

Policy Statements and Historical Documents

The OCGA staff

Categories: AIDS, HIV, global health, antiretroviral drugs

THE NATIONAL ACADEMIES

Institute of Medicine

Board on Global Health

Committee on Examining the Probable Consequences of Alternative Patterns

of Widespread Antiretroviral Drug Use in Resource-Constrained Settings

******

Congressional Briefing

Tuesday, July 6, 2004 -- 1:30 p.m.

419 Dirksen Senate Office Bldg.

on

Scaling Up Treatment for the Global AIDS Pandemic: Challenges and Opportunities

by

James W. Curran, Dean, Rollins School of Public Health, Emory University, Atlanta, Georgia and Co-Chair, Committee on Examining the Probable Consequences of Alternative Patterns of Widespread Antiretroviral Drug Use in Resource-Constrained Settings, Board on Global Health, Institute of Medicine, The National Academies

With billions of dollars now available to provide HIV/AIDS drugs to developing nations, the questions of when and how to "scale up" treatment for millions of needy individuals must be addressed. Significant challenges remain, including a shortage of health care workers and the possibility that a less-than-optimal introduction of therapy could foster more rapid development of drug resistance. This new report, from the Institute of Medicine, offers a framework and key principles to guide program managers on how best to initiate and run treatment programs.

This briefing was for members of Congress and congressional staff only. The report was publicly released on July 7, 2004 and can be found, in its entirety, on the Web site of the National Academies Press.